← Scroll for more →
Financial Statements — PSNY
Balance Sheet
(in billions USD)| Metric | Q4 2024 | Q4 2023 | Q4 2022 | Q4 2021 |
|---|---|---|---|---|
| Cash & Equivalents | 0.74 | 0.77 | 0.97 | 0.76 |
| Inventory | 1.08 | 0.93 | 0.66 | -- |
| Total Current Assets | 2.30 | 2.27 | 2.18 | -- |
| Total Non-current Assets | 1.76 | 2.02 | 1.76 | -- |
| Total Assets | 4.05 | 4.29 | 3.94 | -- |
| Total Current Liabilities | 4.74 | 3.62 | 3.25 | -- |
| Total Non-current Liabilities | 2.64 | 1.92 | 0.82 | -- |
| Total Liabilities | 7.38 | 5.54 | 4.08 | -- |
| Retained Earnings | (6.91) | -- | (3.73) | -- |
| Total Stockholder Equity | (3.33) | (1.25) | (0.13) | 0.12 |
← Scroll for more columns →
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2023 | Q2 2022 |
|---|---|---|
| Total Revenue | 685.25 | 589.07 |
| Cost of Revenue* | 686.06 | 528.39 |
| Gross Profit | (0.81) | 60.68 |
| Research & Development | 45.61 | 66.67 |
| Selling, General & Admin | 259.63 | 234.23 |
| Total Operating Expenses | 274.35 | 627.27 |
| Pretax Income | (301.45) | (225.50) |
| Tax Provision | 2.61 | 2.74 |
| Net Income | (304.06) | (228.24) |
| Basic EPS | (0.14) | (0.12) |
| Diluted EPS | (0.14) | (0.12) |
← Scroll for more columns →
* Derived from reported values